The company said revenue for the first quarter of fiscal 2025 decreased 4% year over year to $52.3 billion. Excluding the impact of the previously communicated large customer contract expiration, revenue increased 15%, it said.

1. 01

   The company said revenue for the first quarter of fiscal 2025 decreased 4% year over year to $52.3 billion. Excluding the impact of the previously communicated large customer contract expiration, revenue increased 15%, it said.

2. 02

   The company said GAAP operating earnings for Q1 were $568 million and GAAP diluted earnings per share were $1.70. Non-GAAP operating earnings increased 12% to $625 million, and non-GAAP diluted earnings per share increased 9% to $1.88.

3. 03

   Cardinal Health said it raised its fiscal 2025 full-year non-GAAP diluted earnings per share guidance to $7.75 to $7.90 from $7.55 to $7.70. It also changed its segment profit growth outlook for Pharmaceutical and Specialty Solutions to 4% to 6% from 1% to 3%.

4. 04

   Cardinal Health said net cash used in operating activities was $(1,647) million for Q1, and the change in accounts payable within that figure was $(1,394) million. Cash and equivalents fell from $5,133 million as of June 30, 2024 to $2,867 million as of September 30, 2024.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.